Registration

CAPITOL SOLUTIONS for AMGEN USA

Firm
Client
Income
—
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products

LobbyistCovered position, as disclosed
SARAH CURTIS New N/A
DANIEL C TATE New N/A

Medicare/Medicaid MMM

Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products

LobbyistCovered position, as disclosed
SARAH CURTIS New N/A
DANIEL C TATE New N/A

Health Issues HCR

Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products

LobbyistCovered position, as disclosed
SARAH CURTIS New N/A
DANIEL C TATE New N/A

Budget/Appropriations BUD

Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products

LobbyistCovered position, as disclosed
SARAH CURTIS New N/A
DANIEL C TATE New N/A

Food Industry (safety, labeling, etc.) FOO

Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products

LobbyistCovered position, as disclosed
SARAH CURTIS New N/A
DANIEL C TATE New N/A

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.